🟢 Edesa Biotech is trading 6% up today after rebounding from August 27 decline

Edesa Biotech is trading 6.06% up now at $4.90 after rebounding from the August 27 decline.

• No new company-specific announcement explaining the August 31 move was identified.
• The latest notable company news was an August 19–20 public offering priced at $25.0 million.
• Fiscal third-quarter results were released August 13; these events are not sufficiently current to establish direct causation for today’s gain.